Beckman Coulter to Market New Reagent for Metabolic Disease Screening.
Using the new reagent, analyzers are able to measure denhydroepiandrosterone sulfate (DHEA-S) in samples and deliver results in 29 minutes.
DHEA-S is a kind of steroid hormone which serves as an indicator of adrenal cancer and Cushing's syndrome, as well as metabolic diseases.
The product comes in two packages, Access DHEA-S Reagent packs (2x50 test) and calibrators (6 vials of 2mL/vial).
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Mar 16, 2006|
|Previous Article:||GlaxoSmithKline K.K. to Conduct Clinical Study of HPV Vaccine.|
|Next Article:||Hitachi, Bridgestone to Join Hands in Electronic Paper Display Business.|